JY
HBIO icon

Jeff Yass’s Harvard Bioscience HBIO Stock Holding History

Jeff Yass’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,270
Closed -$54.6K – 12726
2023
Q3 		$54.6K Sell
1,270
-230
-15% -$10.6K ﹤0.01% 11260
2023
Q2 		$82.3K Buy
+1,500
New +$82.3K ﹤0.01% 11089
2013
Q4 		– Sell
-2,664
Closed -$106K – 9107
2013
Q3 		$106K Buy
2,664
+211
+9% +$8.3K ﹤0.01% 8064
2013
Q2 		$88K Buy
+2,453
New +$93.9K ﹤0.01% 7840

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HBIO Position: Q1 2026 in Review

Jeff Yass sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 13,987 shares — an estimated $93.5K sold.

Jeff Yass first reported a position in HBIO in Q3 2013 and held it in 22 quarters. The position peaked at $383K in Q1 2018. 37 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Jeff Yass reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 13,987 Harvard Bioscience shares in Q1 2026, an estimated $93.5K.
  • Jeff Yass first reported a position in Harvard Bioscience in Q3 2013 and held it in 22 quarters.
  • Jeff Yass's Harvard Bioscience position peaked at $383K in Q1 2018.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.